Literature DB >> 34737594

Incidence and Predictors of Chronic Kidney Disease among Diabetes Mellitus Patients: A Retrospective Follow-Up Study at a Tertiary Health-Care Setting of Ethiopia.

Gebiso Roba Debele1, Mohammedamin Hajure2, Haileab Fekadu Wolde3, Melaku Kindie Yenit3.   

Abstract

BACKGROUND: Chronic kidney disease (CKD) is one of the most common microvascular complications of diabetes mellitus (DM) and it is a major health burden worldwide. Despite the increasing trend of microvascular complications in developing countries, there is limited evidence on predictors of CKD among diabetic patients in Ethiopia. Therefore, this study was aimed to assess the incidence and predictors of CKD among DM patients.
METHODS: A retrospective follow-up study was conducted among type 1 and type 2 DM patients in Southwest Ethiopia. A total of 437 newly-diagnosed diabetes patients were selected using a simple random sampling technique. Data were extracted from patients' medical records. Cox proportional hazard model was fitted and a 95% confidence interval was used to select significant variables.
RESULTS: Overall, 15.56% of patients developed CKD, with an incidence rate of 2.29 per 1,000 person-month (PM) (95% CI=1.79-2.93). Female sex (AHR=0.51, 95% CI=0.27-0.94) was found to be a protective factor of CKD, while positive proteinuria (AHR=2.85, 95% CI=1.48-5.55), having hypertension (HTN) (AHR=2.31, 95% CI=1.03-5.56), and high-density lipoprotein cholesterol (HDL-C) <40 mg/dL (AHR=3.19, 95% CI=1.73-5.98) were significant predictors of CKD.
CONCLUSION: CKD among DM patients continues to be a significant public health problem in health-care settings of Ethiopia. The current study found being female was protective, while positive proteinuria, HTN, and HDL-C <40 mg/dL were risk factors for CKD. We recommend health professionals to give more attention to DM patients with the identified risk factors.
© 2021 Debele et al.

Entities:  

Keywords:  chronic kidney disease; diabetes mellitus; incidence; predictors

Year:  2021        PMID: 34737594      PMCID: PMC8560326          DOI: 10.2147/DMSO.S335572

Source DB:  PubMed          Journal:  Diabetes Metab Syndr Obes        ISSN: 1178-7007            Impact factor:   3.168


  55 in total

1.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

2.  The challenges of renal replacement therapy in Asia.

Authors:  Georgi Abraham
Journal:  Nat Clin Pract Nephrol       Date:  2008-12

3.  Complement inhibitors targeted to the proximal tubule prevent injury in experimental nephrotic syndrome and demonstrate a key role for C5b-9.

Authors:  Chun He; Masaki Imai; Hongbin Song; Richard J Quigg; Stephen Tomlinson
Journal:  J Immunol       Date:  2005-05-01       Impact factor: 5.422

4.  Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study.

Authors:  P Muntner; J Coresh; J C Smith; J Eckfeldt; M J Klag
Journal:  Kidney Int       Date:  2000-07       Impact factor: 10.612

Review 5.  Worldwide access to treatment for end-stage kidney disease: a systematic review.

Authors:  Thaminda Liyanage; Toshiharu Ninomiya; Vivekanand Jha; Bruce Neal; Halle Marie Patrice; Ikechi Okpechi; Ming-hui Zhao; Jicheng Lv; Amit X Garg; John Knight; Anthony Rodgers; Martin Gallagher; Sradha Kotwal; Alan Cass; Vlado Perkovic
Journal:  Lancet       Date:  2015-03-13       Impact factor: 79.321

6.  Progression of diabetic nephropathy, risk of end-stage renal disease and mortality in patients with type-1 diabetes.

Authors:  Yassamine Bentata; Intissar Haddiya; Hanane Latrech; Kalid Serraj; Redouane Abouqal
Journal:  Saudi J Kidney Dis Transpl       Date:  2013-03

7.  Tight blood pressure control decreases apoptosis during renal damage.

Authors:  Karina Soto; Dulcenombre Gómez-Garre; Raquel Largo; Julio Gallego-Delgado; Nuria Tejera; Marina P Catalán; Alberto Ortiz; Juan José Plaza; Covadonga Alonso; Jesús Egido
Journal:  Kidney Int       Date:  2004-03       Impact factor: 10.612

Review 8.  Chronic kidney disease: global dimension and perspectives.

Authors:  Vivekanand Jha; Guillermo Garcia-Garcia; Kunitoshi Iseki; Zuo Li; Saraladevi Naicker; Brett Plattner; Rajiv Saran; Angela Yee-Moon Wang; Chih-Wei Yang
Journal:  Lancet       Date:  2013-05-31       Impact factor: 79.321

9.  What do we know about chronic kidney disease in India: first report of the Indian CKD registry.

Authors:  Mohan M Rajapurkar; George T John; Ashok L Kirpalani; Georgi Abraham; Sanjay K Agarwal; Alan F Almeida; Sishir Gang; Amit Gupta; Gopesh Modi; Dilip Pahari; Ramdas Pisharody; Jai Prakash; Anuradha Raman; Devinder S Rana; Raj K Sharma; R N Sahoo; Vinay Sakhuja; Ravi Raju Tatapudi; Vivekanand Jha
Journal:  BMC Nephrol       Date:  2012-03-06       Impact factor: 2.388

10.  Associations between sex and incident chronic kidney disease in a prospective diabetic cohort.

Authors:  Margaret K Yu; Wayne Katon; Bessie A Young
Journal:  Nephrology (Carlton)       Date:  2015-07       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.